Chloe Atreya, MD, PHD
NPI 1326058777 · Medical Oncology Physician · San Francisco, CA
Enrolled with Medicare as Practitioner - Medical Oncology · source: CMS PECOS Public Provider Enrollment (2026.04.01)
Chloe Atreya, MD, PHD is a Medical Oncology Physician provider in San Francisco, CA (NPI 1326058777).
Provider details
- NPI number
- 1326058777
- Entity type
- Individual
- Primary specialty
- Medical Oncology PhysicianAllopathic & Osteopathic Physicians
- Credential
- MD, PHD
- Sex
- Female
- Sole proprietor
- No
- License
- A104445 (CA)
Specialties & taxonomies
Allopathic & Osteopathic Physicians
Profile Score
A profile completeness & documented-activity index — NOT a quality, outcomes, or patient-satisfaction rating.
- Registry tenure25% of score
19 yrs in NPPES registry
- Profile completeness25% of score
100% of core fields populated
- Practice footprint15% of score
1 documented practice location
- Medicare service volume (vs. specialty peers)25% of score
363 Medicare services, 2024 (ranked within specialty)
- Open Payments transparency10% of score
Has Open Payments disclosures (2024)
Medicare volume is ranked against active providers in the same specialty. Signals a provider has no public data for (e.g. Medicare claims) are left out of the score entirely — never counted as zero — so providers without that data are not penalized. See the full formula and weights in our .
What this provider does (Medicare)
Based on Medicare fee-for-service claims, 2024; not all care is captured.
| Service (HCPCS) | Medicare services | Typical Medicare-allowed (2024) |
|---|---|---|
| Established Patient Office Or Other Outpatient Visit With High Level of Medical Decision Making, If Using Time, 40 Minutes Or More99215 | 219 | $161 |
| Visit Complexity Inherent to Evaluation and Management Associated With Medical Care Services That Serve As the Continuing Focal Point for All Needed Health Care Services And/Or With Medical Care Services That Are Part of Ongoing Care Related to a Patient'SG2211 | 65 | $19 |
| Prolonged Office Or Other Outpatient Evaluation and Management Service(s) Beyond the Maximum Required Time of the Primary Procedure Which Has Been Selected Using Total Time on the Date of the Primary Service; Each Additional 15 Minutes By the Physician OrG2212 | 44 | $35 |
| New Patient Office Or Other Outpatient Visit With a High Level of Medical Decision Making, If Using Time, 60 Minutes Or More99205 | 23 | $202 |
| Established Patient Office Or Other Outpatient Visit With Moderate Level of Decision Making, If Using Time, 30 Minutes Or More99214 |
What this provider prescribes (Medicare Part D)
Top drugs by Medicare Part D claim volume, 2024 · 5 distinct drugs on file.
| Drug | Part D claims (2024) | Beneficiaries |
|---|---|---|
| Trifluridine/Tipiracil Hclbrand: Lonsurf | 43 | — |
| Sunitinib Malate | 25 | — |
| Prochlorperazine Maleate | 24 | — |
| Ondansetron Hcl | 20 | 13 |
| Apixabanbrand: Eliquis | 13 | — |
Medicare Part D only. These counts cover prescriptions paid through Medicare Part D in 2024 — they do notinclude cash-pay, commercial-insurance, Medicaid, or Part B–administered drugs, and badly undercount high cash-pay categories (e.g. GLP-1 weight-loss, testosterone, and ED medications). Any drug with 10 or fewer claims is omitted by CMS, and beneficiary counts under 11 are suppressed — so a missing drug means no Part D record, never zero. This is a factual claims summary, not an endorsement, not medical advice, and not a consumer report. Source: CMS Medicare Part D Prescribers — by Provider and Drug.
Transparency — industry payments
Based on CMS Open Payments, 2024; not all care is captured.
$2,899 across 3 records (Open Payments 2024)
Open Payments discloses payments and transfers of value (meals, travel, consulting, research, royalties) from drug and device makers to providers. This is a transparency signal, not a verdict — such payments are legal and common, and their presence is neither an endorsement nor a criticism. Source: CMS Open Payments, program year 2024.
Practice location
Mailing address
Registry dates
- Enumerated
- 2006-08-08
- Last updated
- 2012-11-30
Frequently asked questions
- What is Chloe Atreya's NPI number?
- Chloe Atreya's National Provider Identifier (NPI) is 1326058777, a unique 10-digit ID issued by CMS for use in standard healthcare transactions.
- What is Chloe Atreya's specialty?
- Chloe Atreya is listed in the NPPES registry with a primary specialty of Medical Oncology Physician (Allopathic & Osteopathic Physicians).
- Where is Chloe Atreya located?
- Chloe Atreya's practice location on file with NPPES is 1600 Divisadero St, San Francisco, CA 94115-3010.
- What is Chloe Atreya's phone number?
- The practice phone number listed in the NPPES registry for Chloe Atreya is (415) 353-9888.
- Does Chloe Atreya accept Medicare?
- Chloe Atreya is approved to bill Medicare according to CMS PECOS enrollment data (2026.04.01). Confirm current participation with the provider before scheduling.
- Is Chloe Atreya's NPI active?
- Yes — Chloe Atreya's NPI (1326058777) is active in the NPPES registry as of the last update on 2012-11-30.
Source: CMS NPPES Data Dissemination (June 2026). NPI Central is not affiliated with CMS. Data is provided as-is from the public registry.